Study to Investigate the Penetration of Rifabutin Into the Lung After Multiple Intravenous Administrations of BV100
NCT05684705 · Status: COMPLETED · Phase: PHASE1 · Type: INTERVENTIONAL · Enrollment: 35
Last updated 2025-01-14
Summary
Study to Investigate the Penetration of Rifabutin Into the Lung After Multiple Intravenous Administrations of BV100
Conditions
Interventions
- DRUG
-
BV100
Intravenous infusion
Sponsors & Collaborators
-
CW-Research and Management GmbH
collaborator UNKNOWN -
BioVersys AG
lead INDUSTRY
Principal Investigators
-
Lisa Husband, MD · BioVersys SAS
Study Design
- Allocation
- NA
- Purpose
- TREATMENT
- Masking
- NONE
- Model
- SINGLE_GROUP
Eligibility
- Min Age
- 18 Years
- Max Age
- 55 Years
- Sex
- ALL
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2023-09-01
- Primary Completion
- 2024-10-30
- Completion
- 2024-12-30
Countries
- Austria
Study Locations
More Related Trials
-
Improved Use of Antibiotic Guidelines in Hospital Environment
NCT00512772 ·Status: COMPLETED
-
Comparative Study of NXL103 Versus Comparator in Adults With Community Acquired Pneumonia
NCT00653172 ·Status: COMPLETED ·Phase: PHASE2
-
COVID-19 Active Research Experience (CARE)
NCT04368065 ·Status: COMPLETED
-
Study to Determine and Compare Plasma and Intrapulmonary Pharmacokinetics of WCK 2349 in Healthy Adult Human Subjects
NCT02253342 ·Status: COMPLETED ·Phase: PHASE1
-
Improving Antibiotic Use in Acute Care Treatment
NCT00144040 ·Status: COMPLETED ·Phase: NA
-
Biodistribution and Dosimetry Evaluation of [124I]FIAU
NCT01337466 ·Status: COMPLETED ·Phase: PHASE1
-
Rapid Analysis of Infections by Spectrometry of Exhaled Breath
NCT03299608 ·Status: RECRUITING
-
Safety and Efficacy Study of BT086 to Evaluate Adjunctive Therapy in sCAP
NCT01420744 ·Status: COMPLETED ·Phase: PHASE2
-
Clarithromycin v Ciprofloxacin Added to Rifampicin + Ethambutol, for Opportunist Mycobacterial Pulmonary Disease
NCT00367913 ·Status: COMPLETED ·Phase: PHASE4
-
Reducing Antimicrobial Overuse Through Targeted Therapy for Patients With Community-Acquired Pneumonia
NCT05568654 ·Status: ACTIVE_NOT_RECRUITING ·Phase: NA
-
Azithromycin Microspheres in Patients With Low Risk Community Acquired Pneumonia
NCT00140023 ·Status: COMPLETED ·Phase: PHASE3
-
Customized Antibiotic Treatment Duration Among Hospitalized Patients With Moderately Severe Community-Acquired Pneumonia
NCT05903352 ·Status: RECRUITING ·Phase: PHASE3
-
A Study to Investigate Acute Respiratory Virus Infections in Participants at High Risk for Severe Illness
NCT05661604 ·Status: COMPLETED
-
Longitudinal FolloW-up of Antimicrobial Resistance From Perinatal Acquisition (LWAPA): A SHARE Study ASSESSING AND PREVENTING Antimicrobial Resistance in the Perinatal Period
NCT06617260 ·Status: ACTIVE_NOT_RECRUITING
-
A Study to Assess Immunity to Specific Microbial Antigens in Healthy Smokers and Non-smokers and in Subjects With Stable COPD
NCT01516437 ·Status: COMPLETED ·Phase: NA
-
Treatment Monitoring for NTM Infections With a Symptom Diary
NCT07131774 ·Status: RECRUITING
-
Residual SARS-CoV-2 Presence in the Respiratory Tract and Lung Parenchyma (After SARS-CoV-2 Infection or COVID-19)
NCT04775134 ·Status: RECRUITING
-
OPT101 in Patients With Community Acquired Pneumonia (CAP) With Sepsis
NCT06669403 ·Status: NOT_YET_RECRUITING ·Phase: PHASE1
-
Epidemiological Multicohort Study of Latent COVID-19 Infections
NCT04695678 ·Status: COMPLETED
-
Fast Identification of Pathogen in the Setting of Pneumonia Using Multiplex PCR
NCT01858974 ·Status: COMPLETED
-
Monitoring Patients for Developing Communicable and Opportunistic Infections and for Responding to Therapy
NCT00001477 ·Status: COMPLETED
-
Lithium Long COVID Dose-finding Study
NCT06108297 ·Status: COMPLETED ·Phase: PHASE1
-
Ultra Low Doses of Therapy With Radiation Applicated to COVID-19
NCT04394182 ·Status: SUSPENDED ·Phase: NA
-
Leflunomide in Mild COVID-19 Patients
NCT04361214 ·Status: TERMINATED ·Phase: PHASE1
-
Point of Care Polymerase Chain Reaction (PCR) Diagnostics of Respiratory Tract Infections in General Practice
NCT06120153 ·Status: ACTIVE_NOT_RECRUITING ·Phase: NA